Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(12), P. 1749 - 1749
Published: Nov. 24, 2023
The
newly
introduced
COVID-19
vaccines
have
reduced
disease
severity
and
hospitalizations.
However,
they
do
not
significantly
prevent
infection
or
transmission.
In
the
same
context,
measuring
IgM
IgG
antibody
levels
is
important,
but
it
does
provide
information
about
status
of
mucosal
immune
response.
This
article
describes
a
comprehensive
mapping
IgA
epitopes
S
protein,
its
cross-reactivity,
development
an
ELISA-peptide
assay.IgA
epitope
was
conducted
using
SPOT
synthesis
sera
from
RT-qPCR
COVID-19-positive
patients.
Specific
cross-reacting
were
identified,
evolutionary
analysis
early
Wuhan
strain
to
Omicron
variant
performed
bioinformatics
tools
microarray
peptides.
selected
chemically
synthesized
evaluated
ELISA-IgA.A
total
40
identified
with
23
in
S1
17
S2
subunit.
Among
these,
at
least
showed
cross-reactivity
DENV
other
organisms
24
associated
coronaviruses.
Three
MAP4
polypeptides
validated
by
ELISA,
demonstrating
sensitivity
90-99.96%
specificity
100%.
six
IgA-RBD
epitopes,
only
SC/18
variants
(BA.2
BA.2.12.1)
presented
single
epitope.This
research
unveiled
epitome
protein
many
that
exhibit
retains
conserved
except
for
one
(#SCov/18).
suggests
limitations
whole
S1/S2/RBD
segment
serological
diagnostic
tests
COVID-19.
expression
these
specific
as
biomarkers
could
facilitate
monitoring
immunity
COVID-19,
potentially
leading
more
accurate
diagnoses
alternative
vaccines.
Language: Английский
Assessment of the Humoral Immune Response to the SARS-CoV-2 Spike Protein Receptor Binding Motif
Published: Nov. 7, 2023
Global
economic
and
social
burden
was
caused
by
the
SARS-CoV-2
spread
worldwide.
Despite
end
of
pandemic,
there
is
a
concern
about
virulent
evolving
variants
virus
which
can
bypass
humoral
immune
response
induced
vaccination
or
infection.
Crucial
to
viral
entrance,
amino
acid
residues
in
RBM
region,
interacts
with
cellular
receptor
ACE2,
elicit
neutralizing
antibody
response.
Herein
we
determine
immunogenicity
one-dose
heterologous
dose
vaccinated
serum
against
wild-type
mutated
region.
low
RBM,
omicron
possess
four
mutations
(S477N,
T478K,
E484A,
F486V)
that
induce
even
less
titers.
The
most
predominant
responses
were
IgA
IgG.
While
antibodies
(nAbs)
predominantly
target
RBD,
our
investigation
revealed
diminished
seroreactivity
within
RBD's
crucial
receptor-binding
motif
(RBM),
potentially
impacting
production
protective
nAbs.
S1WT
S2WT
peptides
binding
nAbs
evaluated
through
microscale
thermophoresis,
higher
affinity
(35
nM)
obtained
for
sequence
(GSTPCNGVEGFNCYF),
containing
FNCY
patch.
Our
data
indicates
not
an
immunodominant
region
individuals.
Understanding
intricate
dynamics
its
interplay
evolution
host
genetics
essential
formulation
effective
strategies,
only
but
also
future
emerging
coronaviruses.
Language: Английский